{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:07:18Z","timestamp":1791018438688,"version":"4.1.0"},"reference-count":60,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2005,6,16]],"date-time":"2005-06-16T00:00:00Z","timestamp":1118880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The progression of lymphoedema to elephantiasis associated with increased incidence of episodic adeno\u2010lymphangitis (ADL) is of great concern, as it causes physical suffering, permanent disability and economic loss to lymphatic filariasis patients. This randomized clinical trial aimed to assess the efficacy in terms of reduction of oedema and ADL frequency of three treatment regimens among lymphoedema patients from Orissa, India. The regimens were: (I) oral penicillin \u2013 one tablet of 800\u2003000\u2003U penicillin G potassium twice daily for 12\u2003days\u2010repeated every 3\u2003months for 1\u2003year; (II) diethylcarbamazine \u2013 6\u2003mg\/kg bodyweight for 12\u2003days\u2010repeated every 3\u2003months for 1\u2003year; and (III) topical antiseptic, i.e. betadine ointment. Foot care was part of all regimens. All three drug regimens are efficacious in reducing oedema and frequency of ADL episodes. Although the efficacy was slightly higher in regimen I, the difference was not significant. About half of all patients had reduced oedema after the 90\u2003days of treatment, with oedema reduction of 75\u2013100% in 20%. A major proportion of the remaining patients had oedema reduced by less than 25%. The proportion of people whose oedema reduced was slightly but not significantly lower in regimen II. <jats:sc>anova<\/jats:sc> revealed that lymphoedema reduction varied according to grade; being greatest at grade 1 lymphoedema, followed by grade 2. All three regimens significantly reduced ADL frequency after 1\u2003year of treatment. This may be because of foot care as well as use of antibiotics. The estimated costs of treatment per patient for a period of 3\u2003months are US$2.4, 1.5 and 4.0 respectively for regimen I, II and III. Thus affordable treatments with simple antibiotics and foot care can give substantial relief to the patients and reverse early lymphoedema.<\/jats:p>","DOI":"10.1111\/j.1365-3156.2005.01442.x","type":"journal-article","created":{"date-parts":[[2005,6,16]],"date-time":"2005-06-16T08:22:11Z","timestamp":1118910131000},"page":"698-705","source":"Crossref","is-referenced-by-count":37,"title":["A randomized clinical trial to compare the efficacy of three treatment regimens along with footcare in the morbidity management of filarial lymphoedema"],"prefix":"10.1111","volume":"10","author":[{"given":"A. S.","family":"Kerketta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. V.","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. K.","family":"Jangid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. K.","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,6,16]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-2276.2003.01146.x"},{"key":"e_1_2_6_3_1","first-page":"707","article-title":"Lymphatic filariasis in Khurda district of Orissa, India an epidemiological study","volume":"32","author":"Babu BV","year":"2001","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(02)00030-X"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","unstructured":"BadgerC SeersK PrestonN&MortimerP(2004)Antibiotics\/anti\u2010inflamatories for reducing acute inflammatory episodes in lymphoedema of limbs. Cochrane database Syst Rev (2): CD003143.","DOI":"10.1002\/14651858.CD003143.pub2"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4269\/ajtmh.2002.66.163","article-title":"Reactivity to bacterial, fungal, and parasite antigens in patients with lymphedema and elephantiasis","volume":"66","author":"Baird JB","year":"2002","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(98)91028-8"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1993.11812763"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6911.1037"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/000331979304400208"},{"key":"e_1_2_6_11_1","first-page":"566","article-title":"Double\u2010blind placebo\u2010controlled evaluation of clinical activity and safety of Daflon 500\u2003mg in the treatment of acute hemorrhoids","volume":"45","author":"Cospite M","year":"1994","journal-title":"Angiology"},{"key":"e_1_2_6_12_1","first-page":"516","article-title":"Cumulative exposure and its relationship with chronic filarial disease in bancroftian filariasis","volume":"25","author":"Das PK","year":"1994","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(01)90260-3"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2883-2-5"},{"key":"e_1_2_6_15_1","first-page":"137","article-title":"Transmission dynamics of filariasis in Khurda district of Orissa, India","volume":"29","author":"Dash AP","year":"1998","journal-title":"South East Asian Journal of Tropical Medicine and Public Health"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90140-2"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(00)01778-6"},{"key":"e_1_2_6_18_1","first-page":"32","article-title":"Chronic infection of cats with Brugia malayi and Streptococcus","volume":"11","author":"Ewert A","year":"1980","journal-title":"South East Asian Journal of Tropical Medicine and Public Health"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-198906000-00007"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4269\/ajtmh.1995.52.258","article-title":"Lymphoscintigraphic assessment of the effect of Diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis","volume":"52","author":"Freedman DD","year":"1995","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/000331979704800113"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/00034983.1996.11813024","article-title":"The economic burden of lymphatic filariasis in Northern Ghana","volume":"19","author":"Gyapong JO","year":"1996","journal-title":"Annals of Tropical Medicine and Parasitology"},{"key":"e_1_2_6_23_1","volume-title":"Statement of General Principles on Ethical Considerations Involving Human Subjects. Ethical Guideline of Biomedical Research in Human Subjects 1\u20138","author":"ICMR","year":"2000"},{"key":"e_1_2_6_24_1","first-page":"55","article-title":"Tissue tonometry: a useful tool for assessing filarial lymphedema","volume":"25","author":"Kar SK","year":"1992","journal-title":"Lymphology"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000179264"},{"key":"e_1_2_6_26_1","first-page":"192","article-title":"Evaluation of sequential intermittent pneumatic compression in filarial lymphoedema","volume":"15","author":"Manjula Y","year":"2002","journal-title":"The National Medical Journal of India"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/000331979404500614","article-title":"Safety and security of Daflon 500\u2003mg in venous insufficiency and in hemorrhoidal disease","volume":"45","author":"Meyer OC","year":"1994","journal-title":"Angiology"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182000066646"},{"key":"e_1_2_6_29_1","first-page":"637","article-title":"Endemic lymphangitis in French Guiana and its relation to W. bancrofti filariasis","volume":"14","author":"Montestruc E","year":"1960","journal-title":"Indian Journal of Malariology"},{"key":"e_1_2_6_30_1","first-page":"126","article-title":"Episodic dermatolymphangitis (DLA) in patients with lymphoedema from lower extremities before and after administration of benzithine pencillin: a preliminary study","volume":"29","author":"Olszewski WL","year":"1996","journal-title":"Lymphology"},{"key":"e_1_2_6_31_1","first-page":"193","article-title":"Skin changes in filarial lymphoedema","volume":"13","author":"Olszewski WL","year":"1992","journal-title":"Progress of Lymphology"},{"key":"e_1_2_6_32_1","first-page":"40","article-title":"Skin changes in filarial and non filarial lymphoedema of lower extremities","volume":"44","author":"Olszewski WL","year":"1993","journal-title":"Tropical Medicine and Parasitology"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(99)00029-7"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2000.00620.x"},{"key":"e_1_2_6_35_1","first-page":"491","article-title":"Strategies and tools for the control\/elimination of lymphatic filariasis","volume":"75","author":"Ottesen EA","year":"1997","journal-title":"Bulletin of World Health Organization"},{"key":"e_1_2_6_36_1","first-page":"260","article-title":"Diethylcarbamazine and supportive measures for the treatment of brugian filariasis","volume":"2","author":"Pani SP","year":"1989","journal-title":"The National Medical Journal of India"},{"key":"e_1_2_6_37_1","first-page":"200","article-title":"Clinical manifestation in malayan filariasis with special reference to lymphoedema grading","volume":"81","author":"Pani SP","year":"1990","journal-title":"Indian Journal of Medical Research"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90666-5"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470513446.ch3"},{"issue":"1","key":"e_1_2_6_40_1","first-page":"39","article-title":"Evaluation by lymphoscintigraphy of the effect of a micronized flavonoid fraction (Daflon 500\u2003mg) in the treatment of upper limb lymphedema","volume":"14","author":"Pecking AP","year":"1995","journal-title":"International Angiology"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/000331979704800115"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1997.d01-406.x"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1997.d01-406.x"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1999.00351.x"},{"key":"e_1_2_6_45_1","first-page":"55","article-title":"Factors influencing response to lymphono\u2010venous shunt in filarial lymphoedema","volume":"12","author":"Rao VG","year":"1999","journal-title":"The National Medical Journal of India"},{"key":"e_1_2_6_46_1","first-page":"301","article-title":"A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities","volume":"26","author":"Shenoy RK","year":"1995","journal-title":"South East Asian Journal of Tropical Medicine and Public Health"},{"key":"e_1_2_6_47_1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/00034983.1998.11813316","article-title":"Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb","volume":"92","author":"Shenoy RK","year":"1998","journal-title":"Annals of Tropical Medicine and Parasitology"},{"key":"e_1_2_6_48_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00034983.1999.11813433","article-title":"A double blind placebo controlled study of the efficacy of oral pencillin diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphodema caused by brugian filariasis","volume":"93","author":"Shenoy RK","year":"1999","journal-title":"Annals of Tropical Medicine and Parasitology"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1159\/000054072"},{"key":"e_1_2_6_50_1","first-page":"826","article-title":"Estimation of ASO titer as an indicator of streptococcal infection precipitating acute adenolymphangitis in brugian lymphatic filaria","volume":"28","author":"Suma TK","year":"1997","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2002.00914.x"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2883-2-4"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.2307\/3284723"},{"key":"e_1_2_6_54_1","first-page":"186","article-title":"Filariasis among white immigrants in Samoa","volume":"46","author":"Webster EH","year":"1943","journal-title":"US Naval Medical Bulletin"},{"key":"e_1_2_6_55_1","volume-title":"Fourth Report of the WHO Expert Committee on Filariasis","author":"WHO","year":"1984"},{"key":"e_1_2_6_56_1","volume-title":"Lymphatic Pathology and Immunopathology in Filariasis","author":"WHO","year":"1985"},{"key":"e_1_2_6_57_1","volume-title":"Lymphatic Filariasis: Disease and its Control","author":"WHO","year":"1992"},{"key":"e_1_2_6_58_1","volume-title":"Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products","author":"WHO","year":"1995"},{"key":"e_1_2_6_59_1","first-page":"2","article-title":"Coumarin (Lodema)","volume":"10","author":"WHO","year":"1996","journal-title":"WHO Pharmaceutical Newsletter"},{"key":"e_1_2_6_60_1","volume-title":"Declaration of Helsinki\u2010Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects","author":"World Medical Association","year":"1995"},{"key":"e_1_2_6_61_1","first-page":"122","article-title":"The sequential pneumatic compression device in surgery for lymphedema in the limbs","volume":"24","author":"Zelikovski A","year":"1993","journal-title":"Journal of Cardiovascular Surgery (Tarino)"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3156.2005.01442.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3156.2005.01442.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T04:11:37Z","timestamp":1696911097000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3156.2005.01442.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,16]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1111\/j.1365-3156.2005.01442.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3156.2005.01442.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,16]]}}}